150 related articles for article (PubMed ID: 7909971)
1. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
Conrad M; Goldstein D; Andresson T; Schlegel R
Virology; 1994 May; 200(2):796-800. PubMed ID: 7909971
[TBL] [Abstract][Full Text] [Related]
2. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell transformation by papillomavirus E5 proteins.
DiMaio D; Mattoon D
Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
Pim D; Collins M; Banks L
Oncogene; 1992 Jan; 7(1):27-32. PubMed ID: 1311063
[TBL] [Abstract][Full Text] [Related]
5. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Dixon AM; Frank JB; Xia Y; Ely L; Gerstein M; Engelman DM; DiMaio D
J Mol Biol; 2004 May; 338(5):907-20. PubMed ID: 15111056
[TBL] [Abstract][Full Text] [Related]
6. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.
Hwang ES; Nottoli T; Dimaio D
Virology; 1995 Aug; 211(1):227-33. PubMed ID: 7645215
[TBL] [Abstract][Full Text] [Related]
7. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
RodrÃguez MI; Finbow ME; Alonso A
Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
[TBL] [Abstract][Full Text] [Related]
8. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism.
Waters CM; Overholser KA; Sorkin A; Carpenter G
J Cell Physiol; 1992 Aug; 152(2):253-63. PubMed ID: 1639860
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
[TBL] [Abstract][Full Text] [Related]
11. Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours.
Borzacchiello G; Russo V; Gentile F; Roperto F; Venuti A; Nitsch L; Campo MS; Roperto S
Oncogene; 2006 Feb; 25(8):1251-60. PubMed ID: 16205631
[TBL] [Abstract][Full Text] [Related]
12. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.
Goppelt-Struebe M; Fickel S; Reiser CO
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
14. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation.
Suprynowicz FA; Baege A; Sunitha I; Schlegel R
Oncogene; 2002 Mar; 21(11):1695-706. PubMed ID: 11896601
[TBL] [Abstract][Full Text] [Related]
15. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.
Petti L; DiMaio D
J Virol; 1994 Jun; 68(6):3582-92. PubMed ID: 8189497
[TBL] [Abstract][Full Text] [Related]
16. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.
Grindlay GJ; Campo MS; O'Brien V
Virus Res; 2005 Mar; 108(1-2):29-38. PubMed ID: 15681052
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
20. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein.
Petti LM; Ray FA
Cell Growth Differ; 2000 Jul; 11(7):395-408. PubMed ID: 10939593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
